← Leaderboards
Thomas A Ficht
Texas Agrilife Research
$9,295,546
Attributed
$9,692,826
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$9,692,826 · 6
By mechanism
R01$5,017,538 · 3
U54$4,502,272 · 2
R41$173,016 · 1
Top collaborators
- Allison R Ficht2 shared
- Jianxun Jim Song1 shared
Others in their field
Top investigators on “Mutant”
- Kc Kent Lloyd · University Of California At Davis$103,993,616
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Bruce A Beutler · Ut Southwestern Medical Center$34,438,453
- Oscar A. Carretero · Henry Ford Health System$33,594,856
- Stuart H Orkin · Children'S Hospital Boston$33,454,343
- Tracy T Batchelor · Dana-Farber Cancer Inst$31,851,614
Research focus
MutantVaccinesVirulenceInnovationInfectionBrucella VaccineGenesBaseOrganismExpectationAdverse EffectsBrucellaImmunePreventAntigensIn VitroKillingsIn Vivo ModelAttenuatedSafetyControlled ReleaseBrucella Melitensis BacteriumOralMicroencapsulations
Grant awards (20)
Combating melanoma with an attenuated bacterial therapeutic$621,545
R01 · FY2023 · CA
Improved Live Attenuated Brucella Vaccines to Reduce Human Diseases$572,464
R01 · FY2017 · HD · contact PI
Improved Live Attenuated Brucella Vaccines to Reduce Human Diseases$614,459
R01 · FY2016 · HD · contact PI
Improved Live Attenuated Brucella Vaccines to Reduce Human Diseases$585,485
R01 · FY2015 · HD · contact PI
Evaluation fo Live Attenuated B. Melitensis Vaccines in Nonhuman Primates$929,571
U54 · FY2013 · AI · contact PI
Evaluation fo Live Attenuated B. Melitensis Vaccines in Nonhuman Primates$975,633
U54 · FY2012 · AI · contact PI
Evaluation fo Live Attenuated B. Melitensis Vaccines in Nonhuman Primates$888,236
U54 · FY2011 · AI · contact PI
Evaluation fo Live Attenuated B. Melitensis Vaccines in Nonhuman Primates$515,065
U54 · FY2010 · AI · contact PI
Evaluation fo Live Attenuated B. Melitensis Vaccines in Nonhuman Primates$721,736
U54 · FY2009 · AI · contact PI
Improved Brucella Vaccine Strains$346,491
R01 · FY2009 · AI · contact PI
Encapsulated Vaccines Against Select Agents$73,059
R41 · FY2009 · AI
Evaluation of Live Attenuated B. melitensis Vaccines$472,031
U54 · FY2008 · AI · contact PI
Improved Brucella Vaccine Strains$346,491
R01 · FY2008 · AI · contact PI
Encapsulated Vaccines Against Select Agents$99,957
R41 · FY2008 · AI
Improved Brucella Vaccine Strains$353,201
R01 · FY2007 · AI · contact PI
Improved Brucella Vaccine Strains$355,202
R01 · FY2006 · AI · contact PI
Improved Brucella Vaccine Strains$363,750
R01 · FY2005 · AI
Improved Brucella Vaccine Strains$291,000
R01 · FY2003 · AI
Improved Brucella Vaccine Strains$276,450
R01 · FY2002 · AI
Improved Brucella Vaccine Strains$291,000
R01 · FY2001 · AI